ADAPALENE

ADAPALENE was reported 181216 times

ADAPALENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMICAL BURN OF SKIN 1802 0.7103
1 CHEMICAL PEEL OF SKIN 18 0.6207
2 SKIN FRAGILITY 1480 0.6076
3 SKIN BURNING SENSATION 41932 0.5847
4 SKIN IRRITATION 26501 0.5779
5 ACNE 39447 0.5197
6 DIAMINE OXIDASE DEFICIENCY 2 0.5000
7 ACNE CYSTIC 1448 0.4803
8 FIRST DEGREE CHEMICAL BURN OF SKIN 11 0.4583
9 PAIN OF SKIN 12323 0.4572
10 SEBORRHOEA 1577 0.4289
11 DILATED PORES 39 0.4286
12 SENSITIVE SKIN 2826 0.3827
13 ACNE PUSTULAR 287 0.3500
14 SKIN HYPOPIGMENTATION 610 0.3446
15 DRY SKIN 45465 0.3403
16 SKIN DISCOMFORT 863 0.3196
17 SKIN HYPERPIGMENTATION 2745 0.3191
18 SKIN SWELLING 2310 0.2659
19 SKIN EXFOLIATION 21410 0.2535
20 CHEMICAL BURN 248 0.2151
21 SKIN TIGHTNESS 903 0.1918
22 ERYTHEMA 38603 0.1876
23 RASH PAPULAR 4148 0.1849
24 SECOND DEGREE CHEMICAL BURN OF SKIN 8 0.1333
25 EYELID EXFOLIATION 91 0.1152
26 RASH MACULAR 3916 0.1119
27 PERIORBITAL IRRITATION 38 0.1111
28 SKIN FISSURES 2038 0.1042
29 DERMATITIS 2058 0.0981
30 SKIN WARM 569 0.0977
31 SCAR 1634 0.0953
32 SCAB 1036 0.0907
33 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16237 0.0900
34 SKIN INJURY 292 0.0880
35 EYELID IRRITATION 192 0.0765
36 EYELID SKIN DRYNESS 89 0.0734
37 THIRD DEGREE CHEMICAL BURN OF SKIN 3 0.0714
38 SKIN REACTION 972 0.0689
39 UNDERDOSE 4950 0.0677
40 SKIN TEXTURE ABNORMAL 62 0.0647
41 BILIRUBIN CONJUGATED 2 0.0625
42 OVERDOSE 13210 0.0612
43 SKIN HAEMORRHAGE 893 0.0602
44 ROSACEA 263 0.0564
45 SKIN DISCOLOURATION 2514 0.0547
46 APPLICATION SITE PHOTOSENSITIVITY REACTION 2 0.0541
47 SUNBURN 392 0.0525
48 PERIORAL DERMATITIS 33 0.0520
49 RASH ERYTHEMATOUS 2441 0.0510
50 SKIN WRINKLING 132 0.0485
51 HYPERSENSITIVITY 8395 0.0452
52 STICKY SKIN 18 0.0451
53 DRUG INEFFECTIVE 53023 0.0402
54 SKIN EROSION 127 0.0394
55 PERIORBITAL INFLAMMATION 9 0.0390
56 SWELLING FACE 2515 0.0386
57 MILIA 14 0.0386
58 EYELID RASH 36 0.0368
59 SKIN DISCHARGE 14 0.0366
60 RASH 15746 0.0361
61 SKIN INDURATION 73 0.0352
62 DERMAL CYST 83 0.0338
63 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 242 0.0337
64 EYE SWELLING 1197 0.0321
65 JUVENILE MYOCLONIC EPILEPSY 2 0.0317
66 PRURITUS 11887 0.0309
67 PURGING 3 0.0288
68 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2054 0.0288
69 APPLICATION SITE DRYNESS 97 0.0285
70 SWELLING OF EYELID 176 0.0280
71 LIP ERYTHEMA 22 0.0275
72 TANNING 4 0.0272
73 BLISTER 1481 0.0263
74 FURUNCLE 201 0.0253
75 BURNS FIRST DEGREE 7 0.0246
76 PERIORBITAL SWELLING 131 0.0231
77 PERIORBITAL PAIN 19 0.0224
78 ERYTHEMA OF EYELID 115 0.0212
79 MILIARIA 36 0.0209
80 KERATOSIS PILARIS 5 0.0200
81 URTICARIA 3312 0.0198
82 SKIN ABRASION 90 0.0190
83 SKIN INFECTION 210 0.0187
84 EPHELIDES 10 0.0185
85 GAMMA-GLUTAMYLTRANSFERASE 2 0.0183
86 AMYLASE DECREASED 2 0.0180
87 EYELID PAIN 36 0.0177
88 CONDITION AGGRAVATED 5274 0.0173
89 SKIN INDENTATION 8 0.0169
90 THERAPEUTIC PRODUCT EFFECT DECREASED 754 0.0168
91 PRODUCT USE IN UNAPPROVED INDICATION 3982 0.0161
92 LIP EXFOLIATION 21 0.0158
93 POST INFLAMMATORY PIGMENTATION CHANGE 7 0.0155
94 ACNE FULMINANS 3 0.0153
95 CHLOASMA 7 0.0151
96 DISCHARGE 20 0.0144
97 PUSTULE 34 0.0143
98 DARK CIRCLES UNDER EYES 20 0.0136
99 CHAPPED LIPS 59 0.0136
100 PRODUCT INTOLERANCE 3 0.0135
101 EYE IRRITATION 769 0.0133
102 SKIN WOUND 22 0.0129
103 EYELIDS PRURITUS 40 0.0128
104 SKIN ULCER 318 0.0123
105 SCRATCH 129 0.0122
106 PAPULE 83 0.0118
107 ADVERSE REACTION 143 0.0108
108 ECZEMA 561 0.0107
109 POST CHOLECYSTECTOMY SYNDROME 3 0.0106
110 CARBUNCLE 3 0.0106
111 RASH PUSTULAR 76 0.0104
112 PRODUCT USED FOR UNKNOWN INDICATION 13 0.0103
113 APPLICATION SITE ACNE 5 0.0102
114 INGROWN HAIR 7 0.0101
115 SKIN MASS 67 0.0100
116 PRODUCT USE ISSUE 1856 0.0099
117 SKIN ATROPHY 56 0.0097
118 APPLICATION SITE EXFOLIATION 40 0.0097
119 SKIN HYPERTROPHY 25 0.0089
120 PERFUME SENSITIVITY 5 0.0088
121 SKIN BACTERIAL INFECTION 7 0.0087
122 BLEPHARAL PIGMENTATION 4 0.0079
123 CAPILLARY FRAGILITY 4 0.0078
124 ILEITIS 3 0.0078
125 CHOLESTEROSIS 2 0.0078
126 SKIN ULCER HAEMORRHAGE 3 0.0078
127 DANDY-WALKER SYNDROME 2 0.0077
128 LACRIMATION INCREASED 233 0.0077
129 OCULAR HYPERAEMIA 364 0.0077
130 HEPATITIS C ANTIBODY POSITIVE 2 0.0074
131 LIP DRY 66 0.0073
132 THERMAL BURN 51 0.0072
133 ORTHOSIS USER 2 0.0071
134 EYE ALLERGY 11 0.0071
135 BILIARY DYSKINESIA 12 0.0071
136 SLOW RESPONSE TO STIMULI 9 0.0069
137 EPIPHYSES PREMATURE FUSION 2 0.0066
138 STAPHYLOCOCCAL SKIN INFECTION 8 0.0065
139 BREAST FEEDING 5 0.0064
140 SKIN LESION 175 0.0064
141 FACIAL PAIN 56 0.0063
142 ANOREXIA NERVOSA 2 0.0062
143 DERMATITIS CONTACT 70 0.0061
144 DERMATITIS INFECTED 3 0.0060
145 PIGMENTATION DISORDER 37 0.0060
146 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 319 0.0058
147 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
148 BURNS THIRD DEGREE 6 0.0057
149 RASH PRURITIC 298 0.0055
150 DERMATITIS ALLERGIC 69 0.0055
151 RASH VESICULAR 26 0.0054
152 IMPETIGO 8 0.0054
153 ECZEMA EYELIDS 3 0.0054
154 LIP SWELLING 178 0.0053
155 EYELID OEDEMA 61 0.0052
156 BURNS SECOND DEGREE 9 0.0051
157 EYE BURNS 3 0.0051
158 PARAESTHESIA 795 0.0050
159 EYE PRURITUS 167 0.0050
160 WOUND SECRETION 19 0.0048
161 THYROID HORMONES INCREASED 5 0.0048
162 CYST 59 0.0047
163 HYPOTRICHOSIS 3 0.0047
164 BELLIGERENCE 2 0.0047
165 THERAPY CESSATION 227 0.0044
166 GALLBLADDER CHOLESTEROLOSIS 2 0.0044
167 EXPOSURE DURING PREGNANCY 273 0.0044
168 SKIN LACERATION 46 0.0042
169 CRANIAL NERVE PARALYSIS 2 0.0042
170 SOLAR LENTIGO 4 0.0042
171 BLOOD ALKALINE PHOSPHATASE DECREASED 4 0.0042
172 EXERCISE LACK OF 2 0.0041
173 SKIN SENSITISATION 4 0.0039
174 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
175 ACARODERMATITIS 4 0.0037
176 SUPERFICIAL INJURY OF EYE 4 0.0037
177 SEBORRHOEIC DERMATITIS 6 0.0036
178 INCISION SITE COMPLICATION 3 0.0036
179 NAIL DYSTROPHY 2 0.0036
180 ENTEROBACTER INFECTION 6 0.0036
181 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
182 APPLICATION SITE BURN 17 0.0034
183 IRREGULAR BREATHING 2 0.0034
184 FEELING HOT 207 0.0034
185 JUGULAR VEIN THROMBOSIS 6 0.0034
186 NASAL OEDEMA 6 0.0033
187 PNEUMOMEDIASTINUM 6 0.0033
188 EYE CONTUSION 7 0.0033
189 EAR SWELLING 7 0.0033
190 APPLICATION SITE HYPERSENSITIVITY 4 0.0033
191 MOUTH SWELLING 19 0.0033
192 PHOTOSENSITIVITY REACTION 53 0.0032
193 PULPITIS DENTAL 3 0.0032
194 LIP HAEMORRHAGE 4 0.0031
195 CHOLECYSTITIS CHRONIC 21 0.0031
196 SUBCUTANEOUS ABSCESS 15 0.0031
197 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 19 0.0031
198 BLOOD PRESSURE MEASUREMENT 2 0.0031
199 GALLBLADDER INJURY 6 0.0031
200 PAROTID GLAND ENLARGEMENT 2 0.0031
201 GALLBLADDER PAIN 2 0.0030
202 SKIN OEDEMA 3 0.0030
203 CONGENITAL HAND MALFORMATION 2 0.0029
204 ANGULAR CHEILITIS 2 0.0029
205 APPLICATION SITE INFLAMMATION 4 0.0029
206 FACIAL DISCOMFORT 2 0.0028
207 MYOFASCIAL PAIN SYNDROME 2 0.0028
208 PURULENT DISCHARGE 12 0.0028
209 SKIN WEEPING 10 0.0028
210 INTRACRANIAL VENOUS SINUS THROMBOSIS 3 0.0028
211 LIP PAIN 8 0.0028
212 SOMATIC SYMPTOM DISORDER 3 0.0028
213 MATERNAL EXPOSURE DURING BREAST FEEDING 11 0.0027
214 PERIRECTAL ABSCESS 3 0.0027
215 BLISTER RUPTURE 2 0.0027
216 OESOPHAGEAL DISCOMFORT 2 0.0026
217 APPLICATION SITE PAIN 58 0.0026
218 APPLICATION SITE ERYTHEMA 69 0.0026
219 PHARYNGEAL SWELLING 25 0.0026
220 BLOOD FIBRINOGEN INCREASED 2 0.0025
221 BLEPHARITIS 10 0.0025
222 APPLICATION SITE IRRITATION 31 0.0025
223 CHEMICAL INJURY 2 0.0024
224 XEROSIS 3 0.0024
225 EYELID MARGIN CRUSTING 7 0.0024
226 CSF PROTEIN INCREASED 2 0.0024
227 ALLERGY TO CHEMICALS 3 0.0024
228 APPLICATION SITE SWELLING 12 0.0024
229 DEPERSONALISATION 2 0.0024
230 LIP DISCOLOURATION 3 0.0024
231 LIP PRURITUS 2 0.0023
232 APPLICATION SITE PARAESTHESIA 3 0.0023
233 DERMATITIS ACNEIFORM 14 0.0023
234 EXFOLIATIVE RASH 6 0.0023
235 WISDOM TEETH REMOVAL 3 0.0023
236 DANDRUFF 5 0.0023
237 EXPOSURE VIA BREAST MILK 9 0.0023
238 SKIN PAPILLOMA 9 0.0022
239 SKIN DEPIGMENTATION 3 0.0022
240 HYPERKERATOSIS 12 0.0022
241 HYPERTRICHOSIS 4 0.0022
242 INFLAMMATORY BOWEL DISEASE 21 0.0021
243 ADVERSE EVENT 196 0.0021
244 DRY EYE 106 0.0021
245 EYE PAIN 119 0.0021
246 ACTINOMYCOSIS 2 0.0021
247 MULTI-ORGAN DISORDER 4 0.0020
248 COLON ADENOMA 2 0.0020
249 SKIN STRIAE 3 0.0020
250 PRODUCT ODOUR ABNORMAL 21 0.0020
251 DRUG EXPOSURE BEFORE PREGNANCY 2 0.0020
252 EYE COLOUR CHANGE 2 0.0020
253 MULTIPLE-DRUG RESISTANCE 6 0.0019
254 THERAPEUTIC RESPONSE DECREASED 117 0.0019
255 SECRETION DISCHARGE 24 0.0019
256 CROHN'S DISEASE 13 0.0019
257 BONE DEMINERALISATION 2 0.0019
258 ORAL DISCOMFORT 26 0.0019
259 APPLICATION SITE SCAB 4 0.0019
260 HORDEOLUM 8 0.0018
261 RASH MACULO-PAPULAR 41 0.0018
262 LIP BLISTER 5 0.0018
263 OESOPHAGEAL ULCER 7 0.0018
264 MITRAL VALVE PROLAPSE 3 0.0018
265 COMPLEX PARTIAL SEIZURES 2 0.0018
266 SKIN DISORDER 60 0.0018
267 IDIOPATHIC INTRACRANIAL HYPERTENSION 4 0.0018
268 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
269 MOANING 2 0.0018
270 CARBON DIOXIDE DECREASED 2 0.0017
271 APHTHOUS STOMATITIS 4 0.0017
272 AORTIC THROMBOSIS 2 0.0017
273 PALLOR 47 0.0017
274 OSTEOCHONDROSIS 2 0.0017
275 INFECTED CYST 2 0.0017
276 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
277 EYE INFLAMMATION 15 0.0016
278 APPLICATION SITE WARMTH 2 0.0016
279 OVARIAN CYST RUPTURED 2 0.0016
280 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
281 ABDOMINAL OPERATION 2 0.0015
282 FOLLICULITIS 16 0.0015
283 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
284 JOINT CREPITATION 3 0.0015
285 PRODUCT SIZE ISSUE 8 0.0015
286 CHEILITIS 8 0.0015
287 APPLICATION SITE DISCOLOURATION 6 0.0015
288 EXPIRED PRODUCT ADMINISTERED 49 0.0015
289 MIGRAINE WITH AURA 4 0.0015
290 CORNEAL ABRASION 2 0.0015
291 HAIR GROWTH ABNORMAL 10 0.0014
292 JOINT INSTABILITY 2 0.0014
293 MAST CELL ACTIVATION SYNDROME 2 0.0014
294 HAEMORRHAGE IN PREGNANCY 2 0.0014
295 APPLICATION SITE RASH 19 0.0014
296 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
297 APPLICATION SITE PRURITUS 31 0.0014
298 FAECES PALE 3 0.0013
299 CREPITATIONS 4 0.0013
300 MENTAL FATIGUE 2 0.0013
301 PAPILLOEDEMA 6 0.0013
302 ORAL MUCOSAL EXFOLIATION 2 0.0013
303 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
304 MOUTH INJURY 2 0.0013
305 KERATITIS 4 0.0013
306 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
307 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 91 0.0013
308 NASAL DRYNESS 8 0.0013
309 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0013
310 SWELLING 117 0.0012
311 TENDERNESS 13 0.0012
312 DISINHIBITION 2 0.0012
313 SELF ESTEEM DECREASED 3 0.0012
314 FUNGAL SKIN INFECTION 5 0.0012
315 MEDICAL PROCEDURE 2 0.0012
316 ARTHROPOD STING 2 0.0012
317 ACUTE SINUSITIS 2 0.0012
318 MELANOCYTIC NAEVUS 5 0.0011
319 BREAST CYST 2 0.0011
320 INDURATION 2 0.0011
321 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
322 PRE-EXISTING CONDITION IMPROVED 7 0.0011
323 MADAROSIS 13 0.0011
324 GASTROINTESTINAL INJURY 3 0.0011
325 BURNING SENSATION 78 0.0011
326 NO ADVERSE EFFECT 2 0.0011
327 CEREBRAL VENOUS THROMBOSIS 2 0.0011
328 BODY TEMPERATURE ABNORMAL 2 0.0011
329 INTRACRANIAL PRESSURE INCREASED 6 0.0011
330 LYMPH NODE PAIN 2 0.0011
331 BLOOD CHOLESTEROL DECREASED 2 0.0011
332 ANAL HAEMORRHAGE 3 0.0011
333 BLADDER SPASM 2 0.0011
334 ABORTION INDUCED 10 0.0011
335 HYPOAESTHESIA ORAL 16 0.0011
336 THERAPEUTIC RESPONSE UNEXPECTED 47 0.0010
337 BILIARY COLIC 3 0.0010
338 CONTUSION 99 0.0010
339 ATROPHY 2 0.0010
340 SKIN ODOUR ABNORMAL 4 0.0010
341 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29 0.0010
342 EYE INJURY 3 0.0010
343 DERMATITIS PSORIASIFORM 2 0.0010
344 CHANGE OF BOWEL HABIT 2 0.0010
345 EYE INFECTION 11 0.0010
346 CHOLANGITIS SCLEROSING 2 0.0010
347 IMPULSE-CONTROL DISORDER 2 0.0010
348 HAIR COLOUR CHANGES 12 0.0010
349 THROAT TIGHTNESS 26 0.0010
350 INTENTIONAL UNDERDOSE 7 0.0010
351 PHARYNGOLARYNGEAL PAIN 5 0.0009
352 ANAL FISTULA 5 0.0009
353 WOUND 26 0.0009
354 PERIODONTITIS 2 0.0009
355 ASTHENOPIA 5 0.0009
356 OTITIS MEDIA 3 0.0009
357 FEAR OF DEATH 2 0.0009
358 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
359 DYSPAREUNIA 4 0.0009
360 EYELID DISORDER 2 0.0009
361 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
362 TIBIA FRACTURE 4 0.0009
363 VAGINAL INFECTION 4 0.0008
364 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
365 GASTROINTESTINAL OBSTRUCTION 2 0.0008
366 BLOOD PHOSPHORUS DECREASED 3 0.0008
367 HORMONE LEVEL ABNORMAL 4 0.0008
368 ORAL HERPES 16 0.0008
369 EYE OEDEMA 2 0.0008
370 INFLAMMATION 42 0.0008
371 NEURODERMATITIS 3 0.0008
372 CATHETER SITE HAEMORRHAGE 2 0.0008
373 SNORING 3 0.0008
374 FACE INJURY 3 0.0008
375 HOSTILITY 2 0.0008
376 ILEOSTOMY 2 0.0008
377 LACTOSE INTOLERANCE 2 0.0008
378 GINGIVAL DISORDER 3 0.0008
379 OESOPHAGEAL DISORDER 3 0.0008
380 AORTIC ARTERIOSCLEROSIS 2 0.0008
381 ANHEDONIA 20 0.0008
382 ANGIONEUROTIC OEDEMA 2 0.0007
383 ALCOHOL ABUSE 2 0.0007
384 ANAL FISSURE 4 0.0007
385 ANAL ABSCESS 4 0.0007
386 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
387 APPLICATION SITE REACTION 5 0.0007
388 ABNORMAL SENSATION IN EYE 3 0.0007
389 ENTEROCOLITIS 4 0.0007
390 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
391 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
392 GROWTH RETARDATION 2 0.0007
393 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
394 EYE DISCHARGE 7 0.0007
395 GALLBLADDER DISORDER 12 0.0007
396 CEREBROVASCULAR DISORDER 2 0.0007
397 CRYING 24 0.0007
398 URINE ABNORMALITY 3 0.0007
399 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
400 BLOOD BLISTER 2 0.0006
401 BLOOD CREATININE DECREASED 2 0.0006
402 LACERATION 6 0.0006
403 INFUSION SITE PRURITUS 2 0.0006
404 SNEEZING 14 0.0006
405 PARAESTHESIA ORAL 9 0.0006
406 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
407 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
408 FACET JOINT SYNDROME 2 0.0006
409 NODULE 8 0.0006
410 HEPATIC NEOPLASM 2 0.0006
411 VEIN DISORDER 3 0.0006
412 ANXIETY DISORDER 2 0.0006
413 POST-TRAUMATIC STRESS DISORDER 4 0.0006
414 QUALITY OF LIFE DECREASED 8 0.0006
415 OSTEOPENIA 9 0.0006
416 ADVERSE DRUG REACTION 53 0.0006
417 PHARYNGEAL OEDEMA 9 0.0006
418 TEMPERATURE INTOLERANCE 6 0.0006
419 LEFT VENTRICULAR FAILURE 2 0.0006
420 TRISMUS 3 0.0006
421 VENTRICULAR EXTRASYSTOLES 6 0.0006
422 JAUNDICE CHOLESTATIC 2 0.0006
423 HEART DISEASE CONGENITAL 2 0.0006
424 APPENDICECTOMY 2 0.0006
425 IRRITABLE BOWEL SYNDROME 12 0.0006
426 INJURY 39 0.0006
427 FOOD INTOLERANCE 2 0.0005
428 ORAL DISORDER 4 0.0005
429 PARADOXICAL DRUG REACTION 2 0.0005
430 DENTAL CARIES 6 0.0005
431 PERSONALITY CHANGE 5 0.0005
432 IMPULSIVE BEHAVIOUR 2 0.0005
433 AUTOIMMUNE THYROIDITIS 2 0.0005
434 PSORIASIS 69 0.0005
435 HYPERHIDROSIS 68 0.0005
436 SPUTUM DISCOLOURED 5 0.0005
437 PRODUCT PACKAGING ISSUE 5 0.0005
438 CHOLECYSTECTOMY 6 0.0005
439 DISCOMFORT 32 0.0005
440 CONCUSSION 4 0.0005
441 PANIC DISORDER 2 0.0005
442 ORAL INFECTION 2 0.0005
443 FLUSHING 52 0.0005
444 FUNGAL INFECTION 17 0.0005
445 COELIAC DISEASE 5 0.0005
446 OESOPHAGEAL PAIN 2 0.0005
447 HYPERPHAGIA 2 0.0005
448 OBSTRUCTION 2 0.0005
449 FRUSTRATION TOLERANCE DECREASED 4 0.0005
450 DRY THROAT 5 0.0005
451 SLUGGISHNESS 5 0.0005
452 GOITRE 2 0.0005
453 IMPAIRED QUALITY OF LIFE 7 0.0005
454 CONJUNCTIVITIS 9 0.0005
455 PHARYNGITIS 6 0.0005
456 INFUSION SITE SWELLING 3 0.0005
457 BLEPHAROSPASM 3 0.0005
458 SLEEP APNOEA SYNDROME 9 0.0005
459 AORTIC VALVE INCOMPETENCE 2 0.0005
460 THROAT IRRITATION 21 0.0005
461 VITAMIN D DECREASED 4 0.0005
462 PRODUCT CONTAINER ISSUE 4 0.0005
463 HEREDITARY ANGIOEDEMA 5 0.0005
464 ANAPHYLACTIC SHOCK 12 0.0005
465 SKIN CANCER 10 0.0005
466 PARONYCHIA 2 0.0005
467 OCULAR DISCOMFORT 5 0.0004
468 POSTOPERATIVE WOUND INFECTION 3 0.0004
469 WRONG PRODUCT ADMINISTERED 3 0.0004
470 REBOUND EFFECT 5 0.0004
471 PNEUMOTHORAX 7 0.0004
472 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
473 HIDRADENITIS 4 0.0004
474 BACTERIAL INFECTION 8 0.0004
475 PHOTOPHOBIA 8 0.0004
476 PRODUCT SUPPLY ISSUE 3 0.0004
477 ENDOMETRIOSIS 2 0.0004
478 MEDICATION RESIDUE PRESENT 2 0.0004
479 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
480 DERMATITIS ATOPIC 22 0.0004
481 ACUTE RESPIRATORY FAILURE 8 0.0004
482 DEEP VEIN THROMBOSIS 27 0.0004
483 GUILLAIN-BARRE SYNDROME 2 0.0004
484 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
485 HAEMORRHOIDS 8 0.0004
486 INCORRECT DOSAGE ADMINISTERED 2 0.0004
487 SMALL INTESTINAL OBSTRUCTION 5 0.0004
488 URINARY INCONTINENCE 12 0.0004
489 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
490 HYPOAESTHESIA 60 0.0004
491 DRUG TOLERANCE 2 0.0004
492 AMMONIA INCREASED 2 0.0004
493 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
494 RENAL FAILURE CHRONIC 3 0.0004
495 CACHEXIA 2 0.0004
496 CONGENITAL ANOMALY 3 0.0004
497 SWOLLEN TONGUE 12 0.0004
498 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
499 AFFECTIVE DISORDER 3 0.0004
500 BLOOD ALBUMIN DECREASED 3 0.0004
501 ABORTION SPONTANEOUS 15 0.0004
502 COMPRESSION FRACTURE 2 0.0004
503 SENSORY LOSS 3 0.0004
504 DYSARTHRIA 14 0.0004
505 EMOTIONAL DISTRESS 45 0.0004
506 PHARYNGITIS STREPTOCOCCAL 4 0.0004
507 BIPOLAR DISORDER 4 0.0004
508 OESOPHAGITIS 4 0.0004
509 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
510 NONSPECIFIC REACTION 2 0.0004
511 ATRIAL SEPTAL DEFECT 3 0.0004
512 PULMONARY EMBOLISM 34 0.0004
513 PANIC ATTACK 13 0.0004
514 SENSATION OF FOREIGN BODY 3 0.0004
515 SINUS DISORDER 7 0.0004
516 NEUTROPHILIA 2 0.0004
517 DYSPHAGIA 33 0.0003
518 BLOOD MAGNESIUM DECREASED 3 0.0003
519 TREATMENT NONCOMPLIANCE 19 0.0003
520 HYPERTRIGLYCERIDAEMIA 2 0.0003
521 GROIN PAIN 3 0.0003
522 LYMPHADENOPATHY 12 0.0003
523 COLITIS ULCERATIVE 15 0.0003
524 CHOLELITHIASIS 11 0.0003
525 ODYNOPHAGIA 2 0.0003
526 OROPHARYNGEAL PAIN 31 0.0003
527 PRODUCT SUBSTITUTION ISSUE 19 0.0003
528 BURSITIS 4 0.0003
529 RESTLESSNESS 12 0.0003
530 ANAPHYLACTIC REACTION 18 0.0003
531 MIGRAINE 31 0.0003
532 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
533 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
534 ERYTHEMA MULTIFORME 3 0.0003
535 DIARRHOEA HAEMORRHAGIC 3 0.0003
536 BONE DENSITY DECREASED 10 0.0003
537 CYANOSIS 5 0.0003
538 STEVENS-JOHNSON SYNDROME 7 0.0003
539 RESPIRATORY TRACT CONGESTION 5 0.0003
540 ABSCESS 5 0.0003
541 AFFECT LABILITY 3 0.0003
542 RHINORRHOEA 20 0.0003
543 HERPES SIMPLEX 2 0.0003
544 HEPATITIS ACUTE 2 0.0003
545 VITAMIN D DEFICIENCY 3 0.0003
546 VITREOUS FLOATERS 3 0.0003
547 MULTIPLE FRACTURES 5 0.0003
548 EYE DISORDER 10 0.0003
549 LIGAMENT SPRAIN 3 0.0003
550 DYSMENORRHOEA 4 0.0003
551 HAIR TEXTURE ABNORMAL 4 0.0003
552 ANXIETY 85 0.0003
553 BREAST MASS 2 0.0003
554 PRODUCT ADMINISTRATION ERROR 6 0.0003
555 DEPRESSION 67 0.0003
556 NEUTROPHIL COUNT INCREASED 3 0.0003
557 PERIPHERAL COLDNESS 4 0.0003
558 JOINT EFFUSION 2 0.0003
559 POOR VENOUS ACCESS 3 0.0003
560 MENTAL IMPAIRMENT 7 0.0003
561 NEURALGIA 7 0.0003
562 FORMICATION 2 0.0003
563 AMENORRHOEA 5 0.0003
564 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
565 SEASONAL ALLERGY 4 0.0003
566 NEUTROPENIC SEPSIS 2 0.0003
567 HOT FLUSH 21 0.0003
568 HAEMORRHAGE 29 0.0003
569 GASTROENTERITIS VIRAL 5 0.0003
570 TOOTHACHE 5 0.0003
571 BACK INJURY 3 0.0003
572 MENTAL DISORDER 12 0.0003
573 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
574 MALNUTRITION 3 0.0003
575 OSTEOPOROSIS 11 0.0003
576 HYDRONEPHROSIS 2 0.0003
577 THERAPY NON-RESPONDER 12 0.0003
578 BREAST TENDERNESS 2 0.0003
579 PAROSMIA 2 0.0003
580 DYSPNOEA 150 0.0003
581 ECONOMIC PROBLEM 4 0.0003
582 EAR INFECTION 7 0.0003
583 FEELING JITTERY 5 0.0003
584 PAIN 161 0.0003
585 INSURANCE ISSUE 4 0.0003
586 LIPASE INCREASED 2 0.0003
587 NEOPLASM 3 0.0003
588 MUSCLE TWITCHING 6 0.0003
589 FEAR 7 0.0003
590 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
591 FOOD ALLERGY 2 0.0003
592 DRY MOUTH 21 0.0003
593 THERAPY PARTIAL RESPONDER 4 0.0003
594 BASAL CELL CARCINOMA 4 0.0003
595 PALPITATIONS 30 0.0003
596 INFECTION 37 0.0003
597 GASTROINTESTINAL INFLAMMATION 2 0.0003
598 BRAIN FOG 4 0.0003
599 DRUG SCREEN POSITIVE 2 0.0003
600 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
601 CHOLECYSTITIS 3 0.0003
602 MOOD SWINGS 8 0.0003
603 PREGNANCY 5 0.0002
604 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
605 DECUBITUS ULCER 2 0.0002
606 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
607 STAPHYLOCOCCAL INFECTION 8 0.0002
608 MENSTRUAL DISORDER 2 0.0002
609 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
610 NASAL CONGESTION 14 0.0002
611 FACE OEDEMA 4 0.0002
612 WHEEZING 14 0.0002
613 RETCHING 5 0.0002
614 GASTROINTESTINAL DISORDER 21 0.0002
615 HIATUS HERNIA 3 0.0002
616 MUSCLE STRAIN 2 0.0002
617 CARDIAC MURMUR 2 0.0002
618 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
619 NEUROTOXICITY 4 0.0002
620 IMMUNE SYSTEM DISORDER 3 0.0002
621 TOOTH INFECTION 3 0.0002
622 LYMPHOCYTE COUNT DECREASED 4 0.0002
623 ALOPECIA 44 0.0002
624 LOSS OF LIBIDO 2 0.0002
625 OROPHARYNGEAL DISCOMFORT 2 0.0002
626 ASTHMA 25 0.0002
627 OSTEOMYELITIS 4 0.0002
628 IMPAIRED GASTRIC EMPTYING 3 0.0002
629 MOOD ALTERED 6 0.0002
630 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
631 NERVE COMPRESSION 2 0.0002
632 FEELING COLD 6 0.0002
633 APHONIA 3 0.0002
634 SINUSITIS 22 0.0002
635 APPENDICITIS 2 0.0002
636 FLANK PAIN 2 0.0002
637 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
638 LEUKAEMIA 2 0.0002
639 SINUS TACHYCARDIA 3 0.0002
640 SUICIDAL IDEATION 19 0.0002
641 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
642 ANGER 7 0.0002
643 ATELECTASIS 2 0.0002
644 EAR PAIN 4 0.0002
645 INTENTIONAL PRODUCT MISUSE 18 0.0002
646 GASTROENTERITIS 3 0.0002
647 HEPATOMEGALY 2 0.0002
648 OSTEONECROSIS OF JAW 5 0.0002
649 RESPIRATORY DISORDER 6 0.0002
650 SPINAL FRACTURE 4 0.0002
651 SLEEP DISORDER 14 0.0002
652 ABDOMINAL PAIN 46 0.0002
653 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
654 NECK PAIN 11 0.0002
655 VISION BLURRED 27 0.0002
656 DRUG DISPENSING ERROR 3 0.0002
657 BODY TEMPERATURE INCREASED 4 0.0002
658 HYPONATRAEMIA 11 0.0002
659 EUPHORIC MOOD 2 0.0002
660 INITIAL INSOMNIA 2 0.0002
661 EAR DISCOMFORT 2 0.0002
662 THYROID DISORDER 3 0.0002
663 RASH GENERALISED 5 0.0002
664 PETECHIAE 2 0.0002
665 DYSURIA 7 0.0002
666 INCONTINENCE 2 0.0002
667 JOINT DISLOCATION 2 0.0002
668 EATING DISORDER 4 0.0002
669 PRURITUS GENERALISED 4 0.0002
670 PRODUCT DISPENSING ERROR 4 0.0002
671 ASPIRATION 2 0.0002
672 VENTRICULAR TACHYCARDIA 3 0.0002
673 PLEURAL EFFUSION 11 0.0002
674 FOOT DEFORMITY 2 0.0002
675 VIRAL INFECTION 6 0.0002
676 PYREXIA 62 0.0002
677 BLOOD UREA INCREASED 3 0.0002
678 HEADACHE 112 0.0002
679 CHROMATURIA 4 0.0002
680 AGITATION 13 0.0002
681 MITRAL VALVE INCOMPETENCE 2 0.0002
682 DRUG INTOLERANCE 17 0.0002
683 METRORRHAGIA 3 0.0002
684 INTERNAL HAEMORRHAGE 2 0.0002
685 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
686 HERPES ZOSTER 10 0.0002
687 LETHARGY 10 0.0002
688 ELECTROLYTE IMBALANCE 2 0.0002
689 LIVER FUNCTION TEST ABNORMAL 5 0.0002
690 SURGERY 10 0.0002
691 DEPRESSED MOOD 9 0.0002
692 DRUG ERUPTION 3 0.0002
693 TREATMENT FAILURE 14 0.0002
694 DISEASE RECURRENCE 8 0.0002
695 LEUKOCYTOSIS 3 0.0002
696 HEPATITIS C 2 0.0002
697 APHASIA 5 0.0002
698 PELVIC PAIN 3 0.0002
699 NOCTURIA 2 0.0002
700 FIBROMYALGIA 4 0.0002
701 END STAGE RENAL DISEASE 3 0.0002
702 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
703 THINKING ABNORMAL 3 0.0002
704 EPISTAXIS 12 0.0002
705 INJECTION SITE DISCOLOURATION 2 0.0002
706 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
707 UNEVALUABLE EVENT 12 0.0002
708 BRAIN OEDEMA 2 0.0002
709 COLITIS 6 0.0002
710 ANGIOEDEMA 7 0.0002
711 CHRONIC KIDNEY DISEASE 12 0.0002
712 CHEST PAIN 29 0.0002
713 CHEST DISCOMFORT 16 0.0002
714 DRUG PRESCRIBING ERROR 3 0.0002
715 MYDRIASIS 2 0.0002
716 GENITAL HAEMORRHAGE 2 0.0002
717 INFUSION SITE PAIN 2 0.0002
718 NIGHT SWEATS 5 0.0002
719 INJECTION SITE INDURATION 2 0.0002
720 CHOKING 3 0.0002
721 AMNESIA 10 0.0002
722 RESPIRATORY TRACT INFECTION 4 0.0002
723 MUCOSAL INFLAMMATION 4 0.0002
724 INCORRECT PRODUCT STORAGE 2 0.0002
725 BEDRIDDEN 2 0.0002
726 NASOPHARYNGITIS 28 0.0002
727 ORAL CANDIDIASIS 2 0.0002
728 HEART RATE INCREASED 15 0.0002
729 HAEMATOCRIT DECREASED 3 0.0002
730 SYNCOPE 15 0.0001
731 URINARY RETENTION 5 0.0001
732 IRRITABILITY 9 0.0001
733 MALIGNANT MELANOMA 2 0.0001
734 ABDOMINAL DISCOMFORT 25 0.0001
735 BRONCHITIS 11 0.0001
736 DRUG EFFECT DECREASED 8 0.0001
737 DISTURBANCE IN ATTENTION 8 0.0001
738 BLOOD BILIRUBIN INCREASED 4 0.0001
739 PSORIATIC ARTHROPATHY 6 0.0001
740 OEDEMA 8 0.0001
741 INJURY ASSOCIATED WITH DEVICE 3 0.0001
742 GINGIVAL BLEEDING 2 0.0001
743 ACUTE HEPATIC FAILURE 2 0.0001
744 RESPIRATORY DISTRESS 4 0.0001
745 TOOTH LOSS 3 0.0001
746 PULMONARY HYPERTENSION 3 0.0001
747 HUNGER 2 0.0001
748 HAEMOPTYSIS 4 0.0001
749 MASS 2 0.0001
750 CARPAL TUNNEL SYNDROME 2 0.0001
751 DIZZINESS 71 0.0001
752 IMPAIRED WORK ABILITY 3 0.0001
753 POOR QUALITY SLEEP 3 0.0001
754 CELLULITIS 7 0.0001
755 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
756 HYPERTHYROIDISM 2 0.0001
757 HYPOKINESIA 2 0.0001
758 MUSCULOSKELETAL STIFFNESS 12 0.0001
759 ASCITES 4 0.0001
760 TRANSAMINASES INCREASED 3 0.0001
761 TOOTH DISORDER 3 0.0001
762 RENAL INJURY 4 0.0001
763 IMMUNODEFICIENCY 2 0.0001
764 PANCREATITIS ACUTE 3 0.0001
765 HEART RATE IRREGULAR 3 0.0001
766 LOSS OF CONSCIOUSNESS 17 0.0001
767 INTESTINAL OBSTRUCTION 5 0.0001
768 SUICIDE ATTEMPT 8 0.0001
769 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
770 ABDOMINAL PAIN UPPER 27 0.0001
771 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
772 DEVICE RELATED INFECTION 2 0.0001
773 EMOTIONAL DISORDER 4 0.0001
774 WEIGHT INCREASED 29 0.0001
775 MYALGIA 22 0.0001
776 FEELING ABNORMAL 31 0.0001
777 LIMB DISCOMFORT 4 0.0001
778 ANKLE FRACTURE 2 0.0001
779 BACK PAIN 30 0.0001
780 BLOOD CHOLESTEROL INCREASED 6 0.0001
781 COGNITIVE DISORDER 6 0.0001
782 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
783 INSOMNIA 34 0.0001
784 HAEMATOCHEZIA 7 0.0001
785 INFLUENZA 14 0.0001
786 MULTIPLE SCLEROSIS 6 0.0001
787 PRODUCT QUALITY ISSUE 17 0.0001
788 NAUSEA 99 0.0001
789 BLOOD PRESSURE FLUCTUATION 3 0.0001
790 JOINT SWELLING 15 0.0001
791 MUSCLE TIGHTNESS 2 0.0001
792 PRESYNCOPE 3 0.0001
793 PERIPHERAL SWELLING 19 0.0001
794 BACK DISORDER 2 0.0001
795 PRODUCT DOSE OMISSION 8 0.0001
796 INJECTION SITE URTICARIA 3 0.0001
797 ENCEPHALOPATHY 3 0.0001
798 DYSPEPSIA 12 0.0001
799 COUGH 34 0.0001
800 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
801 DEHYDRATION 16 0.0001
802 RHABDOMYOLYSIS 5 0.0001
803 AGGRESSION 6 0.0001
804 DYSPHONIA 7 0.0001
805 CANDIDA INFECTION 2 0.0001
806 HAEMATEMESIS 3 0.0001
807 INJECTION SITE SWELLING 9 0.0001
808 HEPATITIS 3 0.0001
809 VOMITING 55 0.0001
810 ERECTILE DYSFUNCTION 3 0.0001
811 OFF LABEL USE 102 0.0001
812 RECTAL HAEMORRHAGE 5 0.0001
813 HAEMATOMA 3 0.0001
814 DIPLOPIA 3 0.0001
815 NERVOUSNESS 6 0.0001
816 DEAFNESS 3 0.0001
817 SEDATION 3 0.0001
818 VISUAL IMPAIRMENT 14 0.0001
819 HEAD DISCOMFORT 2 0.0001
820 TACHYCARDIA 10 0.0001
821 MALAISE 49 0.0001
822 JAUNDICE 3 0.0001
823 WEIGHT DECREASED 31 0.0001
824 NEPHROLITHIASIS 5 0.0001
825 PROCEDURAL PAIN 3 0.0001
826 HEPATIC FUNCTION ABNORMAL 4 0.0001
827 MIDDLE INSOMNIA 2 0.0001
828 OEDEMA PERIPHERAL 13 0.0001
829 HEPATIC CIRRHOSIS 2 0.0001
830 FLATULENCE 6 0.0001
831 HYPOCALCAEMIA 2 0.0001
832 FOOT FRACTURE 2 0.0001
833 BLOOD URINE PRESENT 2 0.0001
834 GASTRIC ULCER 2 0.0001
835 INTENTIONAL DOSE OMISSION 3 0.0001
836 NEOPLASM MALIGNANT 7 0.0001
837 INCREASED APPETITE 2 0.0001
838 SOMNOLENCE 21 0.0001
839 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
840 KIDNEY INFECTION 2 0.0001
841 MEMORY IMPAIRMENT 14 0.0001
842 MENORRHAGIA 2 0.0001
843 INJECTION SITE REACTION 7 0.0001
844 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
845 DISORIENTATION 4 0.0001
846 BLOOD PRESSURE ABNORMAL 2 0.0001
847 COMPLICATION OF DEVICE INSERTION 2 0.0001
848 HEPATIC FAILURE 3 0.0001
849 INTENTIONAL SELF-INJURY 2 0.0001
850 STOMATITIS 6 0.0001
851 ILL-DEFINED DISORDER 6 0.0001
852 PRODUCT DOSE OMISSION ISSUE 29 0.0001
853 VERTIGO 6 0.0001
854 BLOOD PRESSURE INCREASED 15 0.0001
855 INJECTION SITE RASH 3 0.0001
856 ILLNESS 10 0.0001
857 NERVOUS SYSTEM DISORDER 3 0.0001
858 ABDOMINAL DISTENSION 10 0.0001
859 MOUTH ULCERATION 2 0.0001
860 BRADYCARDIA 5 0.0001
861 LIVER FUNCTION TEST INCREASED 2 0.0001
862 DEVICE EXPULSION 6 0.0001
863 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
864 FAECES DISCOLOURED 2 0.0001
865 BLOOD CREATININE INCREASED 6 0.0001
866 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
867 OSTEONECROSIS 3 0.0001
868 MELAENA 2 0.0001
869 VISUAL ACUITY REDUCED 3 0.0001
870 LIVER DISORDER 4 0.0001
871 HEPATOTOXICITY 2 0.0001
872 GLOSSODYNIA 2 0.0001
873 ORAL PAIN 2 0.0001
874 FATIGUE 69 0.0001
875 PAIN IN EXTREMITY 26 0.0001
876 HEPATIC ENZYME INCREASED 6 0.0001
877 PERICARDIAL EFFUSION 2 0.0001
878 DELIRIUM 3 0.0001
879 ARRHYTHMIA 4 0.0001
880 ARTHRALGIA 35 0.0001
881 CEREBRAL HAEMORRHAGE 3 0.0001
882 PRODUCTIVE COUGH 4 0.0001
883 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
884 RENAL IMPAIRMENT 7 0.0001
885 INCORRECT DOSE ADMINISTERED 19 0.0001
886 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
887 C-REACTIVE PROTEIN INCREASED 3 0.0001
888 URINARY TRACT INFECTION 14 0.0001
889 DRUG INTERACTION 13 0.0001
890 MUSCLE SPASMS 15 0.0001
891 LUNG DISORDER 4 0.0001
892 DYSPNOEA EXERTIONAL 3 0.0001
893 ABDOMINAL PAIN LOWER 2 0.0001
894 CONSTIPATION 17 0.0001
895 SPEECH DISORDER 4 0.0001
896 GASTRITIS 2 0.0001
897 MENSTRUATION IRREGULAR 2 0.0001
898 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
899 LIMB INJURY 2 0.0001
900 GAIT DISTURBANCE 14 0.0001
901 ABNORMAL DREAMS 2 0.0001
902 MENTAL STATUS CHANGES 2 0.0001
903 MEDICATION ERROR 4 0.0001
904 WITHDRAWAL SYNDROME 3 0.0001
905 OXYGEN SATURATION DECREASED 4 0.0001
906 MUSCULAR WEAKNESS 8 0.0001
907 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
908 THERAPY INTERRUPTED 5 0.0001
909 CONVULSION 4 0.0001
910 HYPERSOMNIA 2 0.0001
911 SEIZURE 8 0.0001
912 PANCREATIC CARCINOMA 2 0.0001
913 DECREASED APPETITE 16 0.0001
914 CONFUSIONAL STATE 11 0.0001
915 RENAL FAILURE 9 0.0001
916 DIARRHOEA 43 0.0001
917 HYPERTENSION 14 0.0001
918 PLATELET COUNT DECREASED 7 0.0001
919 TINNITUS 3 0.0001
920 PNEUMONIA 21 0.0001
921 FEMUR FRACTURE 2 0.0001
922 RENAL DISORDER 3 0.0001
923 DRUG-INDUCED LIVER INJURY 2 0.0001
924 HEAD INJURY 2 0.0001
925 FALL 21 0.0001
926 CYSTITIS 2 0.0001
927 HYPOTHYROIDISM 2 0.0001
928 MOVEMENT DISORDER 2 0.0001
929 THROMBOSIS 5 0.0001
930 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
931 TREMOR 10 0.0001
932 CHILLS 7 0.0001
933 INJECTION SITE PRURITUS 4 0.0001
934 NEUTROPENIA 8 0.0001
935 HOSPITALISATION 9 0.0001
936 GASTRIC DISORDER 2 0.0001
937 NIGHTMARE 2 0.0001
938 ANAEMIA 11 0.0001
939 MUSCULOSKELETAL PAIN 3 0.0001
940 DRUG WITHDRAWAL SYNDROME 5 0.0001
941 PANCREATITIS 3 0.0001
942 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
943 DRUG EFFECT INCOMPLETE 2 0.0001
944 INJECTION SITE PAIN 16 0.0001
945 ATRIAL FIBRILLATION 5 0.0001
946 BONE PAIN 3 0.0001
947 ASTHENIA 19 0.0001
948 INJECTION SITE HAEMORRHAGE 4 0.0001
949 CARDIAC FAILURE CONGESTIVE 4 0.0000
950 EXTRA DOSE ADMINISTERED 2 0.0000
951 DEVICE BREAKAGE 2 0.0000
952 BLINDNESS 2 0.0000
953 NEUTROPHIL COUNT DECREASED 2 0.0000
954 INFLUENZA LIKE ILLNESS 4 0.0000
955 BLOOD GLUCOSE INCREASED 9 0.0000
956 OSTEOARTHRITIS 2 0.0000
957 HYPOACUSIS 2 0.0000
958 COVID-19 8 0.0000
959 DEVICE ISSUE 4 0.0000
960 CARDIAC DISORDER 4 0.0000
961 MOBILITY DECREASED 3 0.0000
962 CEREBROVASCULAR ACCIDENT 7 0.0000
963 INTERSTITIAL LUNG DISEASE 2 0.0000
964 DYSGEUSIA 3 0.0000
965 INJECTION SITE ERYTHEMA 5 0.0000
966 ACUTE KIDNEY INJURY 6 0.0000
967 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
968 CARDIAC FAILURE 3 0.0000
969 CARDIAC ARREST 3 0.0000
970 DRUG DOSE OMISSION 6 0.0000
971 COMPLETED SUICIDE 3 0.0000
972 ARTHROPATHY 2 0.0000
973 BALANCE DISORDER 3 0.0000
974 DISEASE PROGRESSION 4 0.0000
975 CATARACT 2 0.0000
976 NO ADVERSE EVENT 6 0.0000
977 INFUSION RELATED REACTION 2 0.0000
978 BLOOD PRESSURE DECREASED 2 0.0000
979 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
980 HAEMOGLOBIN DECREASED 3 0.0000
981 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
982 MYOCARDIAL INFARCTION 5 0.0000
983 HALLUCINATION 2 0.0000
984 DIABETES MELLITUS 2 0.0000
985 ARTHRITIS 2 0.0000
986 INJECTION SITE BRUISING 2 0.0000
987 BREAST CANCER 2 0.0000
988 NEUROPATHY PERIPHERAL 2 0.0000
989 DEATH 13 0.0000
990 HYPOTENSION 3 0.0000